Filings (90d)
Other insiders active in the same sector
No other insider has filed at Target N. V. Biotech's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mario Schlosser - $62.90M in OSCR purchases and sales in the last 12 months
- BROADWOOD PARTNERS, L.P. - $62.75M in STAA purchases and sales in the last 12 months
- Jonathan M. Rothberg - $62.19M in BFLY purchases and sales in the last 12 months
- Jeffrey M. Leiden - $60.94M in VRTX purchases and sales in the last 12 months
- Dinesh V. Ph D. Patel - $60.58M in PTGX purchases and sales in the last 12 months
- David Cordani - $60.11M in CI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Target N. V. Biotech?
Target N. V. Biotech is a corporate insider of Molecular Templates, Inc. (MTEM). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Target N. V. Biotech last file a Form 4?
The only primary Form 4 on record is dated 18 November 2024.
Has Target N. V. Biotech been buying or selling stock?
Recorded transactions: 2 open-market purchases ($412K) and 1 open-market sale ($846K) across all tracked filings.
